GOALS & ACHIEVEMENTS
Sits firmly at the intersection of health, technology, and execution.
Blake Marggraff is a scientist and entrepreneur, currently serving as Chief Executive Officer of Epharmix, a health IT company creating the first portfolio of clinically proven digital interventions. Epharmix investors and advisors include Peter Diamandis, founder of XPRIZE and Singularity University, and Randy Haykin, founding officer of Yahoo!, Inc. Epharmix leverages clinical trials to validate each disease-specific product (from EpxDiabetes to EpxCongestiveHeartFailure), bringing the gold standard of medical research to efficient, scalable technology.
Blake sits firmly at the intersection of health, technology, and execution. In 2011, Blake received the Gordon E. Moore Award, the top price of the Intel International Science and Engineering Fair, for simulation of novel, inexpensive, and effective cancer treatment and low-tech eukaryotic cell death quantification. Blake's background in research, commercialization, and fundraising have led Blake to give dozens of presentations on to thousands of STEM students across the country.
Prior to graduating from Washington University in St. Louis in May, 2015, Blake balanced academics with rigorous extracurricular work: founding two companies, attending pitch and business plan competitions across the country, and leading the development of new biomedical devices. Blake is a member of the 2015 St. Louis "30 Under 30" class, 2014 Arch Grant winner (of >600 companies from around the world), St. Louis "top 35 innovator," and Inc. Magazine "Coolest College Startup" founder.Back To Ambassadors
awesome things to come